Healthcare Stocks Are Having a Good Year. Should You Buy a Fidelity or iShares ETF to Profit?

Healthcare equities have demonstrated notable outperformance year-to-date, prompting investor interest in sector-specific exchange-traded funds as a capital allocation vehicle. The article compares two distinct approaches: FHLC, a diversified fund holding 334 positions, and IYH, a concentrated portfolio with 100 holdings. This structural divergence raises questions about whether broader diversification or concentrated exposure drives superior risk-adjusted returns in healthcare.

Despite significant portfolio composition differences, both funds have delivered comparable five-year total returns, suggesting that systematic healthcare sector exposure—rather than specific implementation methodology—has been the primary performance driver. This outcome implies that idiosyncratic stock-picking risk within the sector may be minimal relative to macro healthcare tailwinds, whether from aging demographics, pricing dynamics, or innovation cycles. The convergence in returns weakens the case for active manager alpha in this space.

The comparison underscores a critical investment principle: fund structure and position count matter less than underlying sector fundamentals. Large-cap healthcare constituents like JNJ and ABBV likely anchor both portfolios, creating significant performance correlation regardless of total holdings. Investors should focus on sector thesis validity rather than vehicle complexity when considering healthcare exposure.

Sector implication: Healthcare's sustained strength reflects structural demand (demographic aging, chronic disease prevalence) and pricing resilience. However, regulatory risk and cost-containment pressures remain latent headwinds that could compress valuations if political winds shift, particularly around drug pricing reform.